Skip to main content
Livermore
Livermore
ZHEN

LSV Asset Management

SEC CIK
0001050470
Latest filing
Aug 6, 2026

UTHR holding history

United Therapeutics Corp in every 13F filed by LSV Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings

Shares (Q2 2026)
268,370
Value
$145.4M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of UTHR by LSV Asset Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026268,370$145.4M0.3%−130,295−32.7%ReducedHolders
Q1 2026398,665$236.4M0.5%−9,400−2.3%ReducedHolders
Q4 2025408,065$198.8M0.4%−278,645−40.6%ReducedHolders
Q3 2025686,710$287.9M0.6%−177,913−20.6%ReducedHolders
Q2 2025864,623$248.4M0.6%−37,700−4.2%ReducedHolders
Q1 2025902,323$278.2M0.7%−6,401−0.7%ReducedHolders
Q4 2024908,724$320.6M0.7%−60,741−6.3%ReducedHolders
Q3 2024969,465$347.4M0.7%+3,095+0.3%AddedHolders
Q2 2024966,370$307.8M0.7%+436,851+82.5%AddedHolders
Q1 2024529,519$121.6M0.3%+152,151+40.3%AddedHolders
Q4 2023377,368$83.0M0.2%−5,700−1.5%ReducedHolders
Q3 2023383,068$86.5M0.2%+3,700+1.0%AddedHolders
Q2 2023379,368$83.7M0.2%−18,840−4.7%ReducedHolders
Q1 2023398,208$89.2M0.2%−13,810−3.4%ReducedHolders
Q4 2022412,018$114.6M0.3%−153,504−27.1%ReducedHolders
Q3 2022565,522$118.4M0.3%−25,900−4.4%ReducedHolders
Q2 2022591,422$139.4M0.3%−2,980−0.5%ReducedHolders
Q1 2022594,402$106.6M0.2%+57,350+10.7%AddedHolders
Q4 2021537,052$116.0M0.2%+12,766+2.4%AddedHolders
Q3 2021524,286$96.8M0.2%−29,340−5.3%ReducedHolders
Q2 2021553,626$99.3M0.2%−19,770−3.4%ReducedHolders
Q1 2021573,396$95.9M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.